BDTX
Black Diamond Therapeutics Inc.
$2.75
-$0.10(-3.51%)
48
Overall
60
Value
36
Tech
--
Quality
Market Cap
$165.11M
Volume
565.68K
52W Range
$1.20 - $6.33
Target Price
$10.25
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | -- | -- | $1.1M | $3.1M | ||
| Total Revenue | -- | -- | -- | -- | $1.1M | $3.1M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | -- | -- | -- | $1.1M | $3.1M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $29.3M | $69.6M | $126.9M | $92.8M | $86.5M | $78.8M | ||
| Research & Development | $21.8M | $48.2M | $96.8M | $64.4M | $59.4M | $51.3M | ||
| Research Expense | $21.8M | $48.2M | $96.8M | $64.4M | $59.4M | $51.3M | ||
| Selling, General & Administrative | $7.6M | $21.4M | $30.0M | $28.4M | $27.1M | $27.5M | ||
| Selling & Marketing Expenses | $-445.0K | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $7.6M | $21.4M | $30.0M | $28.4M | $27.1M | $27.5M | ||
| Salaries & Wages | $-3.6M | -- | -- | -- | $9.6M | $10.6M | ||
| Depreciation & Amortization | $-47.0K | $52.0K | $205.0K | $508.0K | $437.0K | $343.0K | ||
| Depreciation & Amortization | $-47.0K | $52.0K | $205.0K | $508.0K | $437.0K | $343.0K | ||
| Other Operating Expenses | $-29.3M | $2.4M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-29.3M | $-69.6M | $-126.9M | $-92.8M | $-86.5M | $-78.8M | ||
| EBITDA | $-35.2M | $-67.2M | $-126.7M | $-92.3M | $-82.0M | $-69.3M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | $1.0K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | -- | $-1.0K | -- | $-2.0M | $-1.9M | -- | ||
| Gain on Sale of Securities | $-5.9M | $4.0M | $3.5M | $2.0M | $1.9M | $2.2M | ||
| Other Income/Expense | $5.9M | $-2.3M | $-1.3M | $-372.0K | $-4.0M | $-9.1M | ||
| Other Special Charges | $6.0K | $-1.7M | $-2.2M | $1.9M | $2.1M | $6.9M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $2.9M | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-2.9M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-35.3M | $-67.3M | $-126.9M | $-92.8M | $-82.4M | $-69.7M | ||
| Pre-Tax Income | $-35.3M | $-67.3M | $-125.6M | $-91.2M | $-82.4M | $-69.7M | ||
| NET INCOME | ||||||||
| Net Income | $-35.3M | $-67.3M | $-125.6M | $-91.2M | $-82.4M | $-69.7M | ||
| Net Income (Continuing Operations) | $-35.3M | $-67.3M | $-125.6M | $-91.2M | $-82.4M | $-69.7M | ||
| Net Income (Discontinued Operations) | $-35.3M | $-67.3M | $-125.6M | $-91.2M | $-82.4M | $-69.7M | ||
| Net Income (Common Stockholders) | $-35.3M | $-67.3M | $-125.6M | $-91.2M | $-82.4M | $-69.7M | ||
| TOTALS | ||||||||
| Total Expenses | $29.3M | $69.6M | $126.9M | $92.8M | $86.5M | $78.8M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $2.1M | $32.9M | $36.2M | $36.3M | $44.0M | $55.0M | ||
| Average Shares Outstanding (Diluted) | $2.1M | -- | $36.2M | $36.3M | $44.0M | $55.0M | ||
| Shares Outstanding | $35.9M | $36.1M | $56.9M | $36.5M | $56.9M | $56.7M | ||
| Basic EPS | -- | $-2.05 | $-3.47 | $-2.52 | $-1.88 | $-1.27 | ||
| Basic EPS (Continuing Operations) | -- | $-2.05 | $-3.47 | $-2.52 | $-1.88 | $-1.27 | ||
| Diluted EPS | $-16.99 | $-2.05 | $-3.47 | $-2.52 | $-1.88 | $-1.27 | ||
| Diluted EPS (Continuing Operations) | $-16.99 | -- | $-3.47 | $-2.52 | $-1.88 | $-1.27 | ||
| OTHER METRICS | ||||||||
| Development Expense | -- | -- | -- | $710.0K | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | $-2.3M | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | $-2.3M | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | $5.0K | -- | -- | -- | ||
| Other Gand A | $7.6M | $21.4M | $30.0M | $28.4M | $27.1M | $27.5M | ||
| Rent And Landing Fees | $-415.0K | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $2.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDTX | $2.75 | -3.5% | 565.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Black Diamond Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW